Capugel is a provider of hard capsules and an innovator in drug delivery systems for the pharmaceutical, OTC and health and nutrition industries.
Folllowing the transaction, all Pfizer colleagues currently dedicated to this business will be transferred to Capsugel, which will be under the leadership of Capsugel president and general manager Guido Driesen upon the completion of the transaction.
Driesen said the transaction is an endorsement of Capsugel’s consistent success to date and its potential for future growth with KKR.
The KKR and Pfizer expect to complete the transaction in the third quarter of 2011, assuming the receipt of the required regulatory clearances and satisfaction of other closing conditions.